It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
In vitro maturation (IVM) of oocytes has still a negative impact on the developmental competence of oocytes. Therefore, this study analysed the cumulus proteome of individual cumulus-oocyte complexes (COCs) with and without maturational competence, matured under in vivo or in vitro conditions (n = 5 per group). A novel, ultrasensitive mass spectrometry (MS) based protein profiling approach, using label-free quantification, was applied. The detected cumulus proteome included 2226 quantifiable proteins and was highly influenced by the maturation condition (479 differentially expressed proteins) as well as maturational competence of the corresponding oocyte (424 differentially expressed proteins). Enrichment analysis showed an overrepresentation of the complement and coagulation cascades (CCC), ECM-receptor interaction and steroid biosynthesis in cumulus of COCs that matured successfully under in vivo conditions. Verification of the origin of CCC proteins was achieved through detection of C3 secretion into the maturation medium, with significantly increasing concentrations from 12 (48.4 ng/ml) to 24 hours (68 ng/ml: p < 0.001). In relation, concentrations in follicular fluid, reflecting the in vivo situation, were >100x higher. In summary, this study identified important pathways that are impaired in IVM cumulus, as well as potential markers of the maturational competence of oocytes.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Zurich, Clinic of Reproductive Medicine, Vetsuisse Faculty, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
2 University and ETH Zurich, Functional Genomics Centre Zurich, Zurich, Switzerland (GRID:grid.5801.c) (ISNI:0000 0001 2156 2780)
3 University and ETH Zurich, Functional Genomics Centre Zurich, Zurich, Switzerland (GRID:grid.5801.c) (ISNI:0000 0001 2156 2780); (SIB), Swiss Institute of Bioinformatics, Zurich, Switzerland (GRID:grid.419765.8) (ISNI:0000 0001 2223 3006)
4 University of Zurich, Clinical Laboratory, Department of Clinical Diagnostics and Services, Vetsuisse Faculty, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650); University of Zurich, Center for Clinical Studies, Vetsuisse Faculty, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
5 University of Zurich, Clinical Laboratory, Department of Clinical Diagnostics and Services, Vetsuisse Faculty, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
6 University of Zurich, Institute of Pharmacology and Toxicology, Vetsuisse Faculty, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)